![IJMS | Free Full-Text | Modulatory Effects of Biosynthesized Gold Nanoparticles Conjugated with Curcumin and Paclitaxel on Tumorigenesis and Metastatic Pathways—In Vitro and In Vivo Studies IJMS | Free Full-Text | Modulatory Effects of Biosynthesized Gold Nanoparticles Conjugated with Curcumin and Paclitaxel on Tumorigenesis and Metastatic Pathways—In Vitro and In Vivo Studies](https://www.mdpi.com/ijms/ijms-23-02150/article_deploy/html/images/ijms-23-02150-g001.png)
IJMS | Free Full-Text | Modulatory Effects of Biosynthesized Gold Nanoparticles Conjugated with Curcumin and Paclitaxel on Tumorigenesis and Metastatic Pathways—In Vitro and In Vivo Studies
![MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: Results From XTOSI Pilot Study Up To 12 Months - Edward Choke, Tjun Yip Tang, Eilane Peh, Karthikeyan Damodharan, Shin MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: Results From XTOSI Pilot Study Up To 12 Months - Edward Choke, Tjun Yip Tang, Eilane Peh, Karthikeyan Damodharan, Shin](https://journals.sagepub.com/cms/10.1177/15266028211064816/asset/images/large/10.1177_15266028211064816-fig1.jpeg)
MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: Results From XTOSI Pilot Study Up To 12 Months - Edward Choke, Tjun Yip Tang, Eilane Peh, Karthikeyan Damodharan, Shin
![Feasibility of AC/EC Followed by Weekly Paclitaxel in Node-positive Breast Cancer in Japan | Anticancer Research Feasibility of AC/EC Followed by Weekly Paclitaxel in Node-positive Breast Cancer in Japan | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/29/5/1515/F1.large.jpg)
Feasibility of AC/EC Followed by Weekly Paclitaxel in Node-positive Breast Cancer in Japan | Anticancer Research
Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry | PLOS ONE
![SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016) – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub. SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016) – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.](https://cyberleninka.org/viewer_images/694604/f/1.png)
SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016) – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Chemotherapy Immunotherapy Guidelines and Recommendations For Practice 4 | PDF | Chemotherapy | Immunotherapy
![In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies – topic of research paper in Biological sciences. Download scholarly article PDF and read In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies – topic of research paper in Biological sciences. Download scholarly article PDF and read](https://cyberleninka.org/viewer_images/1329479/f/1.png)
In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies – topic of research paper in Biological sciences. Download scholarly article PDF and read
![Paradigm change in urological, gynaecological and breast cancer management: A new practice-changing data from ASCO 2022 annual meeting - ScienceDirect Paradigm change in urological, gynaecological and breast cancer management: A new practice-changing data from ASCO 2022 annual meeting - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S246829422200168X-fx2.jpg)
Paradigm change in urological, gynaecological and breast cancer management: A new practice-changing data from ASCO 2022 annual meeting - ScienceDirect
![Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial - The Lancet Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/4d74e81b-0230-421c-926f-dfa861831537/gr1.gif)